A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis Academic Article uri icon

Overview

MeSH Major

  • Abatacept
  • Takayasu Arteritis

abstract

  • In patients with TAK, the addition of abatacept to a treatment regimen with prednisone did not reduce the risk of relapse.

authors

publication date

  • April 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5378643

Digital Object Identifier (DOI)

  • 10.1002/art.40037

PubMed ID

  • 28133931

Additional Document Info

start page

  • 846

end page

  • 853

volume

  • 69

number

  • 4